Literature DB >> 8763332

Clinical multidrug resistance in cancer: a multifactorial problem.

M Lehnert1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763332     DOI: 10.1016/0959-8049(96)00069-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  19 in total

1.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

Review 2.  Classical multidrug resistance in acute myeloid leukaemia.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

3.  Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.

Authors:  Yan-Na Cui; Qing-Xing Xu; Pooya Davoodi; De-Ping Wang; Chi-Hwa Wang
Journal:  Acta Pharmacol Sin       Date:  2017-05-29       Impact factor: 6.150

4.  Revisiting Combination Chemotherapy as a Single Modality Palliative Therapy for Advanced Anaplastic Thyroid Carcinoma-a Single Institution Experience.

Authors:  Surabhi Garg; Sasi Mouli; Kul Ranjan Singh; Pooja Ramakant; Anand K Mishra; Chanchal Rana
Journal:  Indian J Surg Oncol       Date:  2021-08-02

5.  5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.

Authors:  Yuxin Zhuang; Guang Yang; Shaoyu Wu; Jianjun Chen; Jiayin Guo; Dongling Quan; Tingting Zhang; Zichao Yang; Shaobin Tan; Yuheng Ji; Zhipeng Chen; Lin Lv
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

6.  Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.

Authors:  Sawitree Chiampanichayakul; Songyot Anuchapreeda; Nuttapol Chruewkamlow; Kodchakorn Mahasongkram; Pattra Thanaratanakorn; Watchara Kasinrerk
Journal:  Int J Hematol       Date:  2010-08-26       Impact factor: 2.490

7.  A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.

Authors:  Colin J Mooney; Govardhanan Nagaiah; Pingfu Fu; Jay K Wasman; Matthew M Cooney; Panos S Savvides; Joseph A Bokar; Afshin Dowlati; Ding Wang; Sanjiv S Agarwala; Susan M Flick; Paul H Hartman; Jose D Ortiz; Pierre N Lavertu; Scot C Remick
Journal:  Thyroid       Date:  2009-03       Impact factor: 6.568

8.  Bypass of tumor drug resistance by antivascular therapy.

Authors:  Dina Preise; Ohad Mazor; Natalia Koudinova; Mordechai Liscovitch; Avigdor Scherz; Yoram Salomon
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

9.  Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.

Authors:  Govardhanan Nagaiah; Akm Hossain; Colin J Mooney; James Parmentier; Scot C Remick
Journal:  J Oncol       Date:  2011-06-12       Impact factor: 4.375

10.  Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

Authors:  M Lehnert; K Mross; J Schueller; B Thuerlimann; N Kroeger; H Kupper
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.